CITIUS ONCOLOGY, INC.
Pharmaceutical Preparations · CRANFORD · NJ
Moderate confidence (50%)
Updated Oct 20, 2026, 12:03 AM
What is happening
Derived by rule set status-rules-2026.09.7
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
Latest material event: CITIUS ONCOLOGY, INC. received a delisting notice from its exchange (Apr 22, 2026)
Timeline
Every material event, newest first. History is never overwritten.
CITIUS ONCOLOGY, INC. received a delisting notice from its exchange
Apr 22, 2026
Delisting notice received
- SEC EDGAR — “Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing . On April 22, 2026, Nasdaq Stock Market LLC ( Nasdaq ) notified Citius Oncology, Inc. (the Company ) that for the last 30 consecutive business days, the bid price for the Company s common stock had closed below the minimum $1.00 per share requirement for continued inclusion on the Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the Bid Price Rule ). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has a compliance period of 180 calendar days, or unt…”
Company information
- Founded
- —
- Employees (estimate)
- —
- Industry
- Pharmaceutical Preparations
- Subindustry
- —
- Listing
- SEC lists the ticker CTOR on Nasdaq.
- SEC CIK
- 0001851484
- Website
- —
- —
- Headquarters
- CRANFORD, NJ
- Also known as
- TenX Keane Acquisition
- Legal entities
- CITIUS ONCOLOGY, INC.
Sources
Every material source used to build this profile.
SEC Company Submissions (TIER 1 · UNVERIFIED)
CITIUS ONCOLOGY, INC. — Pharmaceutical Preparations (SIC 2834) — CRANFORD, NJ
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing . On April 22, 2026, Nasdaq Stock Market LLC ( Nasdaq ) notified Citius Oncology, Inc. (the Company ) that for the last 30 consecutive business days, the bid price for the Company s common stock had closed below the minimum $1.00 per share requirement for continued inclusion on the Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the Bid Price Rule ). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has a compliance period of 180 calendar days, or unt…
View source record
Status history
Every derived status, with the rule that produced it.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:31 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:15 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:31 PM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 14, 2026, 04:45 PM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 04:35 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.